Good Neighbor Pharmacy was the highest-ranked pharmacy in the U.S. for the second year in a row in terms of customer satisfaction, according to consumer insight firm J.D. Power's annual pharmacy satisfaction survey.
The J.D. Power 2020 U.S. Pharmacy Study, released Aug. 5, measures customer satisfaction by surveying more than 12,000 customers who filled a prescription in the three months before the survey period of May to June. J.D. Power looks at metrics such as cost, customer service, and billing and payment services to determine its rankings.
The top-rated chain brick-and-mortar pharmacies for customer satisfaction, along with their index score out of 1,000:
- Good Neighbor Pharmacy (915)
- Health Mart (905)
- Rite Aid (861)
- Walgreens (849)
- CVS/pharmacy (845)
The top-rated mass merchandiser brick-and-mortar pharmacies for customer satisfaction, along with their index score out of 1,000:
- Sam's Club (885)
- Costco (870) (tie)
CVS/pharmacy inside Target (870) (tie) - Walmart (850)
The top-rated supermarket brick-and-mortar pharmacies for customer satisfaction, along with their index score out of 1,000:
- Wegmans (904)
- Publix (889)
- Winn Dixie (883)
- H-E-B (878)
- ShopRite (876)
- Stop and Shop (871)
- Albertsons (867)
- Kroger (866)
- Fry's Pharmacy (860) (tie)
Giant (860) (tie) - Giant Eagle (844)
- Hy-Vee (843)
- King Soopers (837)
- Safeway (829)
The top-rated mail-order pharmacies, along with their index score out of 1,000:
- Humana Pharmacy (904)
- OptumRx (886) (tie)
Kaiser Permanente Pharmacy (886) (tie) - Walmart Pharmacy Mail Services (876)
- Express Scripts (871)
- Cigna Home Delivery Pharmacy Program (861)
- CVS Caremark (852)
- Aetna Rx Home Delivery (845)
- AllianceRx Walgreens Prime (828)
More articles on pharmacy:
An updated timeline on hydroxychloroquine, the controversial potential COVID-19 treatment
Moderna will charge $32 to $37 for COVID-19 vaccine, CEO says
US seeks up to $18.1B from Purdue Pharma
CVS reports strong Q2 results, boosted by lack of elective surgeries
J&J signs $1B+ deal with the US for 100 million COVID-19 vaccine doses
An updated timeline on hydroxychloroquine, the controversial potential COVID-19 treatment